StockNews.com Initiates Coverage on Aptose Biosciences (NASDAQ:APTO)
Analysts at StockNews.com assumed coverage on shares of Aptose Biosciences (NASDAQ:APTO – Get Free Report) (TSE:APS) in a report released on Monday. The firm set a “hold” rating on the biotechnology company’s stock. Separately, HC Wainwright reissued a “buy” rating and issued a $2.00 target price on shares of Aptose Biosciences in a research report […]
Analysts at StockNews.com assumed coverage on shares of Aptose Biosciences (NASDAQ:APTO – Get Free Report) (TSE:APS) in a report released on Monday. The firm set a “hold” rating on the biotechnology company’s stock. Separately, HC Wainwright reissued a “buy” rating and issued a $2.00 target price on shares of Aptose Biosciences in a research report […]
